|
T.N. Markova, A.A. Anchutina, M.S. Stas, M.M. Medzhidova
Features of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus hospitalized with coronavirus infection
|
№12 / 2023
|
|
N.S. Alekseeva
Carbohydrate metabolism disorders and osteoporosis
|
№12 / 2021
|
|
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
|
№4 / 2019
|
|
A.V. Pashentseva, A.F. Verbovoy
HYPOGLYCEMIC THERAPY AND CARDIOVASCULAR SAFETY
|
№13 / 2015
|
|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
O. A. Ettinger
Chronic Heart Failure In Diabetic Patients: Modern Concepts
|
№16 / 2012
|
|
Birukova E.V.
How To Achieve Effective Glycemic Control And Reduce The Risk Of Vascular Complications Due To Using Sulfonylurea Medications
|
№3 / 2011
|
|
I.V. Glinkina
Sulphonylurea Derivatives In The Treatment Of Type 2 Diabetes Mellitus At Current Stage
|
№12 / 2009
|
Русский
